Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 12/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 10/31/10
Due: 10/31/11
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| 18F ML-10 for Early Detection of Response of Brain Metastases to SRS | NCT00696943 | Aposense Ltd. | user2@example.com | None | 2008-07-31 | 2009-07-31 | 2010-07-31 | - | - | 2025-07-14 |
| 18F ML-10 for Early Detection of Response of Brain Metastases to WBRT | NCT00791063 | Aposense Ltd. | user2@example.com | None | 2008-03-31 | 2008-12-31 | 2009-12-31 | - | - | 2025-07-14 |
| An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation | NCT01260480 | Aposense Ltd. | user2@example.com | None | 2010-12-31 | - | - | - | - | 2025-07-14 |
| Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. | NCT00805636 | Aposense Ltd. | user2@example.com | None | 2008-11-30 | 2010-10-31 | 2011-10-31 | - | - | 2025-07-14 |